Evidence map›Paper›PMID 25646093›Full record

ArticleFrontiers in microbiology2014

CS21 positive multidrug-resistant ETEC clinical isolates from children with diarrhea are associated with self-aggregation, and adherence.

Ariadnna Cruz-Córdova, Karina Espinosa-Mazariego, Sara A Ochoa, Zeus Saldaña, Gerardo E Rodea, Vicenta Cázares-Domínguez, Viridiana Rodríguez-Ramírez, Carlos A Eslava-Campos, Armando Navarro-Ocaña, José Arrellano-Galindo and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. RecombinantPathogens (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Genome Sequence of EnterotoxigenicGenome announcements · 2017
    Article
  12. Article
  13. Tracking Bioluminescent ETEC duringFrontiers in cellular and infection microbiology · 2017
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Ariadnna Cruz-CórdovaUnidad de Hemato-Onocología e Investigación, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez Mexico City, Mexico.
Karina Espinosa-MazariegoUnidad de Hemato-Onocología e Investigación, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez Mexico City, Mexico.
Sara A OchoaUnidad de Hemato-Onocología e Investigación, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez Mexico City, Mexico.
Zeus SaldañaUnidad de Hemato-Onocología e Investigación, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez Mexico City, Mexico ; Departamento de Genética Molecular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México Mexico City, Mexico.
Gerardo E RodeaUnidad de Hemato-Onocología e Investigación, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez Mexico City, Mexico ; Departamento de Genética Molecular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México Mexico City, Mexico.
Vicenta Cázares-DomínguezUnidad de Hemato-Onocología e Investigación, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez Mexico City, Mexico.
Viridiana Rodríguez-RamírezUnidad de Hemato-Onocología e Investigación, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez Mexico City, Mexico.
Carlos A Eslava-CamposUnidad de Hemato-Onocología e Investigación, Laboratorio de Patogenicidad Bacteriana, Hospital Infantil de México Federico Gómez Mexico City, Mexico ; Departamento de Salud Pública, Facultad de Medicina, Universidad Nacional Autónoma de México Mexico City, Mexico.
Armando Navarro-OcañaDepartamento de Salud Pública, Facultad de Medicina, Universidad Nacional Autónoma de México Mexico City, Mexico.
José Arrellano-GalindoLaboratorio de Infectología, Departamento de Infectología, Hospital Infantil de México Federico Gómez Mexico City, Mexico.
Rigoberto Hernández-CastroDepartamento de Ecología de Agentes Patógenos, Hospital General "Dr. Manuel Gea González," Mexico City, Mexico.
Oscar G Gómez-DuarteDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University School of Medicine Nashville, TN, USA.
Firdausi QadriCentre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research Dhaka, Bangladesh.
Juan Xicohtencatl-CortesUnidad de Hemato-Onocología e Investigación, Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez Mexico City, Mexico.
Hospital Infantil de México Federico Gómez · MXUniversidad Nacional Autónoma de México · MXHospital General Dr. Manuel Gea Gonzalez · MXInternational Centre for Diarrhoeal Disease Research · BDVanderbilt University · US

Funding

Studies on Emergent Diarrheagenic E. coli PathogensR01AI095346 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOMEZ, OSCAR G · 2013 to 2017
$1.9M
NIAID NIH HHS R01 AI095346
6 · The paper itself

Abstract

backgroundEnterotoxigenic Escherichia coli (ETEC) colonize the human intestinal mucosa using pili and non-pili colonization factors (CFs). CS21 (also designated Longus) is one of the most prevalent CFs encoded by a 14 kb lng DNA cluster located in a virulence plasmid of ETEC; yet limited information is available on the prevalence of CS21 positive ETEC isolates in different countries. The aim of this study was to evaluate the prevalence of CS21 among ETEC clinical isolates from Mexican and Bangladeshi children under 5 years old with diarrhea and to determine the phenotypic and genotypic features of these isolates.

methodsETEC clinical isolates positive to lngA gene were characterized by genotype, multidrug-resistance, self-aggregation, biofilm formation, and adherence to HT-29 cell line.

resultsA collection of 303 E. coli clinical isolates were analyzed, the 81.51% (247/303) were identified as ETEC, 30.76% (76/247) were st (+)/lt (+), and 25.10% (62/247) were positive for the lngA gene. Among the lngA (+) ETECs identified, 50% of isolates (31/62) were positive for LngA protein. The most frequent serotype was O128ac:H12 found in 19.35% (12/62) of lngA (+) ETEC studied. Multidrug-resistance (MDR) lngA (+) ETEC isolates was identified in 65% (39/60), self-aggregation in 48.38% (30/62), and biofilm formation in 83.87% (52/62). ETEC lngA (+) isolates were able to adhere to HT-29 cells at different levels. Two lngA isogenic mutants were constructed in the ETEC E9034A and ETEC73332 clinical isolate, showing a 77% and 98% reduction in adherence, respectively with respect to the wild type.

conclusionETEC isolates that have the lngA gene showed features associated with self-aggregation, and adherence to HT-29 cells, important characteristics in the human gut colonization process and pathogenesis.

Indexed as

biofilmCS21ETECmultidrug-resistanceself-aggregation and adherence

Identifiers

PMID25646093
PMCPMC4297921
OpenAlexW2003828930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.